Provided by Tiger Trade Technology Pte. Ltd.

Trane Technologies PLC

432.42
-1.2500-0.29%
Volume:667.71K
Turnover:288.15M
Market Cap:95.88B
PE:33.31
High:433.38
Open:431.74
Low:427.03
Close:433.67
52wk High:479.37
52wk Low:298.15
Shares:221.74M
Float Shares:221.74M
Volume Ratio:0.47
T/O Rate:0.30%
Dividend:3.76
Dividend Rate:0.87%
EPS(TTM):12.98
EPS(LYR):12.98
ROE:36.96%
ROA:11.64%
PB:11.18
PE(LYR):33.32

Loading ...

Trane Leans on Commercial Strength to Balance Residential Weakness, RBC Says

MT Newswires Live
·
Oct 31, 2025

Trane Technologies Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Oct 31, 2025

Argus Research Sticks to Their Buy Rating for Trane Technologies (TT)

TIPRANKS
·
Oct 31, 2025

Oppenheimer Sticks to Its Hold Rating for Trane Technologies (TT)

TIPRANKS
·
Oct 31, 2025

RBC Capital Remains a Hold on Trane Technologies (TT)

TIPRANKS
·
Oct 31, 2025

Citigroup Adjusts Price Target on Trane Technologies to $513 From $494, Maintains Buy Rating

MT Newswires Live
·
Oct 31, 2025

Trane Technologies Reports Strong Third Quarter Results

prnewswire
·
Oct 31, 2025

KeyBanc Remains a Hold on Trane Technologies (TT)

TIPRANKS
·
Oct 31, 2025

TT Electronics Reiterates Intention to Back Cicor's $377 Million Takeover Bid

Dow Jones
·
Oct 31, 2025

TT Electronics Favors Cicor Offer Over DBAY’s Proposals

TIPRANKS
·
Oct 31, 2025

Trane Technologies PLC Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 31, 2025

Stock Track | Trane Technologies Soars 5% Pre-Market on Q3 Earnings Beat and Strong Bookings Growth

Stock Track
·
Oct 30, 2025

GUIDANCE: (TT) Trane Technologies Expects 2025 Adjusted Continuing EPS Range $12.95 - $13.05, vs. FactSet Est of $12.97

MT Newswires Live
·
Oct 30, 2025

Earnings Flash (TT) Trane Technologies Posts Q3 Adjusted Continuing EPS $3.88, vs. FactSet Est of $3.78

MT Newswires Live
·
Oct 30, 2025

Trane Technologies Q3 Adj. EPS $3.88 Beats $3.78 Estimate, Sales $5.743B Miss $5.787B Estimate

Benzinga
·
Oct 30, 2025

Trane Technologies Q3 Net Revenues Rise 6% to $5.74 Billion

Reuters
·
Oct 30, 2025

TT Investments Extends Takeover Offer for 360 Capital Group

TIPRANKS
·
Oct 30, 2025

AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026

GlobeNewswire
·
Oct 27, 2025

AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing

GlobeNewswire
·
Oct 26, 2025

History’s Largest Infrastructure Cycle Has Begun

InvestorPlace
·
Oct 25, 2025